# Anti-MERS-CoV Convalescent Plasma Therapy

> **NCT02190799** · PHASE2 · WITHDRAWN · sponsor: **King Abdullah International Medical Research Center**

## Conditions studied

- Respiratory Distress Syndrome (& [Hyaline Membrane Disease])

## Interventions

- **BIOLOGICAL:** Convalescent plasma

## Key facts

- **NCT ID:** NCT02190799
- **Lead sponsor:** King Abdullah International Medical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02190799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02190799, "Anti-MERS-CoV Convalescent Plasma Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02190799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*